MEDIPOST Co., Ltd. (KOSDAQ:078160)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Cell Therapy Sales Division	20.30B	21.74B	19.63B	17.23B	16.44B
Cell Therapy Sales Division Growth	-6.64%	10.74%	13.92%	4.84%	3.11%
Health Function Food Sector	8.85B	9.55B	9.88B	9.71B	7.47B
Health Function Food Sector Growth	-7.33%	-3.33%	1.79%	29.95%	36.11%
Adjustment and Removal	-3.46B	-3.02B	-472.62M	-58.76M	-1.99M
Cord Blood Division	39.18B	32.69B	29.51B	25.77B	21.03B
Cord Blood Division Growth	19.82%	10.77%	14.52%	22.55%	-5.40%
Others	5.79B	7.68B	5.65B	2.20B	3.69B
Others Growth	-24.61%	35.99%	156.37%	-40.29%	71.63%
Total	70.66B	68.64B	64.20B	54.86B	48.62B
Total Growth	2.93%	6.92%	17.03%	12.82%	6.14%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
South Korea	70.64B	-	-	-	-
Export	21.03M	-	-	-	-
Total	70.66B	-	-	-	-

Source: S&P Global Market Intelligence.